Skip to main content

Find Clinical Trials

Home
Conditions
Gastric Cancer Peritoneal Metastases

Clinical trial condition

Gastric Cancer Peritoneal Metastases

Explore clinical trials studying Gastric Cancer Peritoneal Metastases. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Gastric Cancer Peritoneal Metastases trial results

Recruiting

Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

NCT07304271

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer Peritoneal Metastases, +6 more
Locations: Azienda Ospedaliera Universitaria Integrata Verona Verona, Italy

Amsterdam University Medical Center Amsterdam, Netherlands

Sahlgrenska University Hospital Gothenburg, Sweden

Skane University Hospital Lund, Sweden

View Trial Details

Enrolling by Invitation

PIPAC in Gastric Peritoneal Metastasis

NCT07517419

Conditions: Gastric Cancer Peritoneal Metastases
Locations: The Chinese University of Hong Kong, Shatin, HK Hong Kong

View Trial Details

Not Yet Recruiting

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

NCT07304258

Conditions: Gastric Cancer Peritoneal Metastases
Locations: Fourth Affiliated Hospital of Hebei Medical University Shijiazhuang, Hebei, China

View Trial Details